Vanda Pharmaceuticals reported $0 in Debt for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Debt Change
Acorda Therapeutics ACOR:US USD 187.69M 2.71M
Agios Pharmaceuticals AGIO:US USD 1.14M 84K
Akebia Therapeutics AKBA:US USD 65.95M 32.21M
Alnylam Pharmaceuticals ALNY:US USD 1.02B 338.25M
AstraZeneca AZN:LN USD 29.3B 229M
Bristol Myers Squibb BMY:US USD 39.32B 222M
Clovis Oncology CLVS:US USD 660.38M 13.49M
Enanta Pharmaceuticals ENTA:US USD 1.42M 83K
Esperion Therapeutics ESPR:US USD 259.49M 407K
Halozyme Therapeutics HALO:US USD 1.5B 258.29M
Heron Therapeutics HRTX:US USD 149.23M 52K
Insmed INSM:US USD 807.82M 491K
Intercept Pharmaceuticals ICPT:US USD 332.31M 381.55M
Ligand Pharmaceuticals LGND:US USD 76.65M 38.38M
Moderna Inc MRNA:US USD 1.15B 384M
Novartis NVS:US USD 27.91B 530M
Ptc Therapeutics PTCT:US USD 1.06B 145.39M
Puma Biotechnology PBYI:US USD 97.99M 312K
Takeda 4502:JP JPY 4.29T 449.74B
Teva Pharmaceutical TEVA:IT USD 21.27B 816M
Veracyte VCYT:US USD 1.69M 46K